Inhibition of drug binding to human serum albumin by cholecystographic agents

Farmaco

Volumn 58, Issue 9, 2003, Pages 901-908

  Bertucci, Carlo ^a   Cimitan, Samanta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cholecystographic agents; Circular dichroism; Drug binding; Human serum albumin; Optical biosensor

Indexed keywords

HUMAN SERUM ALBUMIN; IOPANOIC ACID;

ARTICLE; BINDING SITE; BIOSENSOR; CHEMICAL BINDING; CHOLECYSTOGRAPHY; CIRCULAR DICHROISM; DIAGNOSTIC PROCEDURE; DRUG BINDING; DRUG INHIBITION; MEDICAL ASSESSMENT; MEDICAL LITERATURE; PROTEIN CONFORMATION;

EID: 0141564628     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(03)00148-4     Document Type: Article

References (20)

1. T. Peters Jr., All about Albumin: Biochemistry, Genetics, and Medical Applications, Academic Press (Ed.), 1996.
2. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 33:1981;17-53.
3. Bertucci C., Domenici E. Reversible and covalent binding of drugs to human serum albumin: methodological approach and physiological relevance. Curr. Med. Chem. 9:2002;1463-1481.
4. Wainer I.W. Enantioselective high performance liquid affinity chromatography as a probe of ligand-biopolymer interactions: an overview of a different use for HPLC chiral stationary phases. J. Chromatogr. 666:1994;221-234.
5. Hage D.S. High-performance affinity chromatography: a powerful tool for studying serum protein binding. J. Chromatogr. B. 768:2002;3-30.
6. C. Bertucci, P. Salvadori, Circular dichroism in the study of stereoselective binding of drugs to serum proteins, in: H.Y. Aboul-Enein, I.W. Wainer (Eds.), The Impact of Stereochirality on Drug Development and Use, Chemical Analysis Series 1997, 142, pp. 521-543.
7. Jönsson U., Fägerstam L., Ivarsson B., Johnsson B., Karlsson R., Lundh K., Löfås S., Persson B., Ross H., Rönnberg I., et al. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques. 11:1991;620-627.
8. Myzka D.G., Rich R.L. Implementing surface plasmon resonance biosensors in drug discovery. PSTT. 3:2000;310-317.
9. Cush R., Cronin J.M., Stewart W.J., Maule C.H., Molloy J., Goddard N.J. The resonant mirror: a novel optical biosensor for direct sensing of biomolecular interactions part I: Principle of operation and associated instrumentation. Biosens. Bioelectron. 8:1993;347-353.
10. Buckle P.E., Davies R.J., Kinning T., Yeung D., Edwards P.R., Pollard-Night D., Lowe C.R. The resonant mirror: a novel optical biosensor for direct sensing of biomolecular interactions part II: applications. Biosens. Bioelectron. 8:1993;355-363.
11. Lowe P.A., Alwyn Clark T.J.H., Davies R.J., Edwards P.R., Kinning T., Yeung D. New approaches for the analysis of molecular recognition using the IAsys evanescent wave biosensor. J. Mol. Recog. 11:1998;194-199.
12. C. Bertucci, S. Cimitan, Rapid screening of small ligand affinity to human serum albumin by an optical biosensor, J. Pharm. Biomed. Anal. in press.
13. Braga M., Cooper D.S. Oral cholecystographic agents and the thyroid. J. Clin. Endocrinol. Metab. 86:2001;1853-1860.
14. Bertucci C., Domenici E., Salvadori P. Stereochemical features of 1,4-benzodiazepin-2-ones bound to human serum albumin: difference circular dichroism and UV studies. Chirality. 2:1990;167-174.
15. Maes V., Engelborghs Y., Hoebeke J., Maras Y., Vercruysse A. Mol. Pharmacol. 21:1982;100-107.
16. Ascoli G., Bertucci C., Salvadori P. Stereospecific and competitive binding of drugs to human serum albumin: a difference circular dichroism approach. J. Pharm. Sci. 84:1995;737-741.
17. Rosen A. The measurement of binding constants using circular dichroism. Binding of phenylbutazone and oxyphenbutazone. Biochem. Pharmacol. 19:1970;2075-2081.
18. Sudlow G., Birkett D.J., Wade D.N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11:1975;824-832.
19. Honoré B. Conformational changes in human serum albumin induced by ligand binding. Pharmacol. Toxicol. 66:(Suppl. II):1990;6-26.
20. Mudge C.H. Cholecystographic agents and drug binding to plasma albumin. Invest. Radiol. 15:1980;102-108.